The Bard IVC Filter class action settlement represents one of the largest legal battles over a medical device failure, with 8,600 lawsuits settled or resolved through the multi-district litigation (MDL) process. These inferior vena cava filters, designed to prevent blood clots from traveling to the lungs, were marketed as temporary devices that could be easily removed—but many patients discovered the filters fragmented, migrated, or perforated their veins, leaving them with permanent complications. Individuals who experienced these failures have recovered substantial compensation, with verdicts and settlements ranging from hundreds of thousands to millions of dollars, reflecting the serious nature of the injuries caused by these defective devices.
The Bard IVC Filter litigation concluded largely in 2021 and 2022, with multiple major verdicts setting a clear pattern of accountability. One plaintiff received a $3.6 million verdict in March 2018 after a jury found Bard liable for producing a device that fragmented without adequate warning—a decision that included $2 million in punitive damages, signaling the jury’s view that the company’s conduct was intentional or reckless. While the main MDL has closed, individual state court cases continue to be filed against Bard, meaning that if you have a documented injury from one of these filters, your legal rights are not foreclosed.
Table of Contents
- What Was the Bard IVC Filter and Why Did It Fail?
- Settlement Amounts and Notable Verdicts in the Bard Case
- The Range of Injuries Caused by Bard IVC Filter Failures
- How to Pursue a Claim Against Bard
- Timeline and Current Litigation Status Against Bard
- The Cook Medical IVC Filter Litigation and Comparison
- Looking Forward—Individual Cases and Future Options
- Conclusion
What Was the Bard IVC Filter and Why Did It Fail?
The bard C2 and G2 IVC filters were temporary vena cava filters manufactured by C.R. Bard, designed to stop blood clots from reaching a patient’s lungs during the recovery period after surgery or trauma. The device consists of a framework of metal struts that unfolds inside the large vein returning blood to the heart, creating a net to catch clots. However, investigations and clinical reports revealed a troubling pattern: the metal frame of Bard’s filters was prone to fracturing during removal, fragmentation inside the vein, tilting to one side, and sometimes perforating the vein wall itself.
When pieces of the filter broke loose, they could travel through the bloodstream and lodge in the heart, lungs, or other vital organs. Clinical complications reported by patients included chest pain, shortness of breath, infection, emergency surgery to retrieve filter fragments, and in severe cases, device embolization (pieces traveling to the heart). Unlike temporary filters from other manufacturers, Bard’s design had a higher documented failure rate during the removal procedure itself. The company knew about these risks through internal testing and received complaints from physicians about filter fractures, yet continued marketing the devices with incomplete warnings and without adequately informing doctors and patients about the removal risks.
Settlement Amounts and Notable Verdicts in the Bard Case
Verdicts and settlements in Bard IVC filter cases have ranged widely based on the severity of injury and the evidence presented. The landmark March 2018 verdict awarded $3.6 million to the first bellwether plaintiff—a case chosen to represent the typical claims—with the jury determining that $2 million should be punitive damages, penalizing the company for its conduct. A 2021 verdict in Oregon awarded a plaintiff named Peterson $926,000 after he suffered documented injuries from filter failure.
In one of the largest individual verdicts, a Wisconsin jury awarded Natalie johnson $3.3 million in August 2021 after a piece of Bard’s filter broke during removal and embedded itself in her heart, requiring emergency intervention. For individuals settling outside of trial, compensation has typically ranged from $200,000 to $750,000 depending on the nature and severity of the injury. Average settlements for significant injury cases have been estimated between $100,000 and $500,000, though cases involving life-threatening complications or multiple surgeries may settle for higher amounts. It’s important to note that settlement offers vary by law firm, jurisdiction, and the specific medical documentation of your injury—two patients with similar complications may receive different offers based on factors like age, pre-existing conditions, and whether the complication required emergency surgery.
The Range of Injuries Caused by Bard IVC Filter Failures
Injuries from Bard IVC filter failures fall into several categories based on when the device failed. The most serious injuries occur when the filter fragments during removal, as happened to Natalie Johnson, whose filter piece embedded in her heart and required emergency cardiac surgery. Other patients experienced perforation of the vein wall, leading to bleeding into the chest cavity, collapsed lungs, or infection requiring prolonged hospitalization.
Some injuries developed slowly, as fragments migrated through blood vessels, causing chronic pain, recurrent infections, or the need for multiple follow-up surgeries to locate and remove fragments. A critical limitation in obtaining compensation is that you must have documented medical evidence of a complication caused by or related to the Bard IVC filter. Simply having the device implanted is not enough—you need imaging studies (CT scans, ultrasound, X-rays) that show fracture, migration, perforation, or another structural failure, plus medical records showing treatment for complications. Patients who never had symptoms or imaging confirmation of a problem will find it extremely difficult to settle or win at trial, even if the filter did technically fail internally.
How to Pursue a Claim Against Bard
If you received a Bard IVC filter and subsequently suffered complications, the first step is to contact a lawyer experienced in medical device litigation. The main Bard IVC filter MDL has closed, meaning no new cases can be added to the coordinated federal litigation, but individual lawsuits can still be filed in state courts where you live or where the injury occurred. A qualified attorney will review your medical records, obtain records from the hospital where the filter was implanted, identify which Bard filter model you received, and determine whether you have a viable claim.
The comparison to other IVC filter litigation is important: Cook Medical faced even larger numbers of lawsuits (11,467 total filed with 6,569 still pending as of April 2026), and individual attorneys represent clients in both the Bard and Cook cases simultaneously. This means that experienced IVC filter lawyers have refined the process of identifying viable claims and negotiating settlements. However, a critical tradeoff is that the later you wait to file, the more likely statutes of limitations will bar your claim—most states allow 2 to 3 years from the time you discovered the injury (the “discovery rule”), but some older cases are being dismissed as time-barred. If you suspect your complications came from filter failure, consulting with an attorney sooner rather than later protects your rights.
Timeline and Current Litigation Status Against Bard
The Bard IVC filter litigation formally ended as an MDL in 2021 and 2022, with the final settlements bringing the total to 8,600 resolved cases. The bellwether trial in 2018 that resulted in the $3.6 million verdict helped establish liability and pushed many cases toward settlement. However, new individual cases continue to be filed in state courts, particularly in states with courts known to be sympathetic to medical device injury claims. As of April 2026, Bard continues to face occasional lawsuits, though the volume is significantly lower than during the height of the MDL.
A warning about relying on settlement data from the MDL: the Bard settlements were largely confidential, meaning the actual settlement amounts for most cases remain undisclosed. What we know about settlement ranges comes from public verdicts, scattered case disclosures, and estimates from law firms involved in the litigation. This means that your individual settlement offer will be based on factors unique to your case, and comparing yourself to publicly known verdicts may not give you an accurate picture of what you should expect to receive. The $3.3 million Wisconsin verdict was exceptional—most cases do not reach that level even at trial.
The Cook Medical IVC Filter Litigation and Comparison
Cook Medical’s IVC filters faced similar design defects and are the subject of ongoing litigation with 11,467 lawsuits filed and 6,569 cases still pending as of April 2026. Cook’s filters exhibited comparable problems to Bard’s—strut fracture, filter tilting, perforation, and complications during retrieval. Many attorneys handling Cook cases also represented Bard plaintiffs, and the legal standards for proving liability are similar.
If you received a Cook IVC filter and suffered complications, your potential recovery would follow a comparable path, though the exact settlement amounts and verdicts in the Cook MDL may differ from Bard’s. The significance of this comparison is that multiple filter manufacturers produced defective devices, suggesting that the problem was not unique to Bard’s design but rather reflected industry-wide practices of marketing temporary filters with inadequate warnings about removal risks. This strengthens the legal argument that manufacturers knew or should have known about the dangers but proceeded with marketing and sales anyway.
Looking Forward—Individual Cases and Future Options
Although the main Bard IVC filter MDL has closed, this does not mean your legal options have expired. Individual state court claims remain available, and as more long-term complications surface in patients who had filters years ago, new lawsuits continue to emerge. Some cases filed today involve filters placed over 10 years ago, as patients experience late complications like chronic infections or gradual vein damage that takes years to manifest.
This forward-looking opportunity means that even if you were not part of the original MDL, you may still have a claim. The future of IVC filter litigation will likely focus on individual state court cases where discovery may reveal additional damaging evidence about what Bard’s engineers knew about failure rates. Some patients are also exploring whether they can pursue claims against hospitals or physicians who implanted or failed to remove the filters properly, though these claims are more complex and face different legal standards.
Conclusion
The Bard IVC filter settlement resolved 8,600 lawsuits and established that the company was liable for marketing a defective device with inadequate warnings. Documented verdicts ranging from $926,000 to $3.6 million demonstrate that serious injuries from filter failure can result in substantial compensation, while settlement ranges of $100,000 to $750,000 reflect the typical outcomes for non-trial cases.
The key to recovering compensation is having documented medical evidence that your filter failed and caused complications requiring treatment. If you received a Bard IVC filter and experienced complications such as chest pain, shortness of breath, device migration, or the need for surgery to remove fragments, contact a medical device injury attorney immediately to evaluate your case. State court litigation remains available even though the federal MDL has concluded, but time limits apply, and you should not delay in protecting your legal rights.